| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.41 | 0.0002 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.093 | 0.003 |